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Introduction
　Hypertension, hyperlipidemia, and impaired glucose tolerance are symptoms of lifestyle-
related diseases that may lead to cardiovascular and cerebrovascular diseases 1, 2）.  Atheroscle-
rosis is the causative factor in most such diseases3）.
Showa Univ J Med Sci 22（1）, 27～40, March 2010
Visceral Fat Accumulation is Associated with Oxidative Stress  
and Increased Matrix Metalloproteinase-9 Expression  
in Atherogenic Factor-overlapped Model Rats
Yuri TOMITA1）, Shinichi IWAI1）, Toshio KUMAI2）,  
Shigeko OHNUMA3）, Chika KURAHASHI1）, Asayo TSUBOI1）,  
Keiichiro OHBA1）, Tomohiro ONO1）, Yoshiomi OKA1）,  
Jyunki KOIKE3）, Shinichi KOBAYASHI2） and Katsuji OGUCHI1）
Abstract : Visceral fat accumulation in lifestyle-related diseases increases the 
risk of atherosclerosis.  Matrix metalloproteinases（MMPs）play an important 
role in the progression of atherosclerosis.  We examined atherogenic factor-
overlapped model rats to clarify the relationships among visceral fat, oxidative 
stress, and MMPs.  We used four groups of male, 11-month-old, spontaneously 
hypertensive hyperlipidemic rats（SHHRs）or Sprague-Dawley（SD）rats. 
Animals were fed either a diet of high fat and 30％ sucrose solution（HFDS）
or a normal diet（ND）ad libitum for 6 months.  The visceral fat weight 
increased by approximately three fold in SHHR-HFDS compared to SHHR-
ND.  The oxidative stress marker in plasma and MMP-9 mRNA expression in 
white blood cells increased in SHHR-HFDS compared to the other groups.  A 
correlation was determined between oxidative stress and visceral fat or MMP-9 
mRNA in all rats.  Lipid deposition and immunostaining of CD68 and MMP-
9 were observed mainly in the intima of aorta in SHHR-HFDS, while tissue 
inhibitor of metalloproteinase-1 mRNA expression decreased in both SHHR 
groups.  The findings suggested that increased oxidative stress due to the 
visceral fat accumulation induced MMP-9 expression and macrophage accumu-
lation in the intima of aorta in lifestyle-related disease model rats.
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　There are few rat models for atherosclerosis, since rats are an atherosclerosis-resistant 
species.  Therefore, we developed a spontaneously hypertensive hyperlipidemic rat（SHHR）
model to study atherogenic factors in the presence of combined hypertension and hyper-
lipidemia.  SHHRs have persistently high levels of systolic blood pressure（SBP）above 
150 mmHg and a plasma total cholesterol concentration above 150 mg / dL.  In addition, 
vascular intimal lesions and lipid deposits were observed under endothelial cells in the aorta 
of SHHRs, but not spontaneously hyperlipidemic rats（HLRs）and controls 4, 5）.  Therefore, 
SHHRs provide a stable model of early vascular degeneration 6）.  Moreover, invasive changes 
occur in the subendothelium of SHHR when nitric oxide（NO）production is inactivated 
followed by a high fat diet and sucrose water treatment（SHHR-HDFS）7）.  Furthermore, 
a previous study found visceral fat accumulation and increased oxidative stress in SHHR-
HFDS 8）.
　Matrix metalloproteinases（MMPs）are zinc ion-dependent enzymes that help to regulate 
the extracellular matrix, cellular migration, and tissue remodeling 9, 10）.  MMPs are associ-
ated with cardiovascular disease and atherosclerosis ; in particular, MMP-2 and MMP-9 play 
important roles in the progression of atherosclerosis 11）, and MMP-9 activity is associated 
with oxidative stress in acute coronary syndrome 12）.  Our previous studies showed that 
plasma MMP-9 activity is signicantly higher and accompanied by aortic lipid deposition in 
SHHR compared to Sprague-Dawley（SD）control rats 5）.  MMP-9’s role in the pathophysi-
ology of atherosclerosis and plaque rupture 13） is tightly regulated by tissue inhibitors of 
metalloproteinases（TIMPs）14）.  In particular, MMP-9 is associated with TIMP-1, a multifunc-
tional protein with the capacity to modulate matrix turnover 15）.
　CD8＋ T cells and macrophages have been linked to considerable amplification of the 
inammatory state in adipose tissue, through the secretion of cytokines and chemokines16, 17）. 
Moreover, systemic oxidative stress is associated with visceral fat accumulation and the 
metabolic syndrome 18, 19）.  We have previously used the diacron reactive oxidative metabolites
（d-ROMs）test as an indicator of oxidative stress20）.  In this study, we examined SHHRs as 
an atherogenic factor-overlapped animal model to clarify the relationship among visceral fat, 
oxidative stress, and MMPs8）.
Materials and Methods
Animals and samples
　Four-month-old male SHHRs and SD rats were divided into two groups : a control group 
fed a regular diet（ND, CE2 ; CLEA Japan, Tokyo）and an HFDS-fed group.  The regular 
diet comprised 8.9％ water, 25.4％ protein, 4.4％ fat, 4.1％ fiber, 6.9％ carbohydrate, and 
50.3％ nitrogen-free extracts, containing 342.2 kcal / 100 g.  The high-fat diet（HFD）con-
sisted of 8.2％ water, 23.4％ protein, 11.0％ fat, 3.8％ ber, 6.3％ carbohydrate, and 46.3％ 
nitrogen-free extracts, containing 378.0 kcal / 100 g.  SD-ND, SD-HFDS, SHHR-ND and 
SHHR-HFDS groups contained 5, 7, 5 and 12 rats, respectively.  Until the age of 4 months, 
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the regular diet was available to all groups ad libitum.  Thereafter, the two HFDS groups 
received NG-nitro-L-arginine methyl ester（L-NAME ; Nacalai Tesque Co., Kyoto, Japan）in 
the drinking water（100 mg / L）for 1 month, and then the high-fat diet with 30％ sucrose 
solution ad libitum for 6 months, thus from 5 to 11 months of age.  The present study 
used SHHR in which the systolic blood pressure was over 150 mmHg, as determined by the 
tailcuff method（PS-100 ; Riken Kaihatsu, Tokyo）.  The rats were housed in a semi-barrier 
system under controlled room temperature（23±1℃）, humidity（55±5％）, and lighting（lights 
on from 6 a.m. to 6 p.m.）.  All studies were conducted according to the “Guiding Principles 
for the Care and Use of Laboratory Animals” of Showa University 21）.
Preparation and biochemical determination of plasma samples
　Blood samples were taken from the inferior vena cava under pentobarbital anesthesia
（35 mg / kg, intraperitoneal administration）and mixed with 3.2％ sodium citrate solution in 
a volume ratio of 9 : 1.  After 15 min of centrifugation at 3,000 rpm, the supernatant, as 
citrated plasma, was used for analysis.  First, the epididymal fat（EpidF）and visceral fat
（VisF）were isolated, and then the visceral fat weight / body weight ratio（VisF / BW）was 
calculated.
　Plasma levels of total cholesterol（TC）and total triglycerides（TG）were determined with 
commercially available kits（Cholesterol E-test and Triglyceride E-test, respectively ; Wako 
Pure Chemicals）8）.  Oxidative stress was measured by a d-ROMs test of rat plasma（Free 
Radical Elective Evaluator ; Wismerll Co. Ltd., Tokyo, Japan）20, 22）.  A 20μL plasma sample 
and 1 mL of buffer solution were gently mixed in a cuvette, before adding 10μL of the 
chromogenic substrate.  After mixing, the cuvette was immediately incubated in the thermo-
static block of the analyzer for 5 min at 37℃, and then absorbance at 505 nm was recorded. 
Measurements are expressed as Carr Units, with 1 Carr corresponding to 0.8 mg / l H2O223）.
Preparation of total RNA
　Blood samples（300μL）and Catrimox-14 Solution（3,000μL）were mixed（Takara Bio, 
Shiga, Japan）, before total RNA was isolated using the Takara FastPure RNA kit and quan-
tied by optical density（260 nm）.  Each RNA sample was diluted with RNase-free water 
and mRNA concentrations were equalized.  Total RNA was reverse transcribed using the 
ExScriptTM RT reagent kit（Takara）.
Quantitative Real-Time PCR
　Q-PCR was used to quantify the mRNA levels of MMP-8, MMP-9, and TIMP-1 in 
rat white blood cells（WBCs）.  The cDNAs were amplified using primers designed by 
ProbeFinder software（Roche Diagnostics K.K., Tokyo, Japan）.  Table 1 details the primers 
used, Roche Universal ProbeLibrary Probe numbers, and accession numbers.  Amplication 
was performed with a LightCycler（Roche）using LightCycler TaqMan Master mix（Roche）. 
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The PCR reaction parameters were as follows : 95℃ for 10 min, 45 cycles of 10 s at 95℃, 
30 s at 60℃, and 1 s at 72℃.  Fluorescence data were analyzed with LightCycler software
（Roche）.  The mRNA levels were compared to 18 s rRNA as a standard, and relative 
expression ratios were obtained 24）.
CT image acquisition and reconstruction
　The computed tomography（CT）studies were performed on 11-month-old rats euthanized 
by overdose with pentobarbital, using the GE Explore Locus CT system（GE Healthcare 
UK Ltd., Buckinghamshire,  England）.  X-ray settings were 80 mA and 50 kVp.  CT images 
were visualized using MicroView 2.0 software（GE Healthcare）.
Morphological study
　The fresh aortic arch was harvested from all rats and stored in saline on ice.  It was then 
dissected from the surrounding tissues and xed in 10％ formalin neutral buffer solution
（pH7.4 ; Wako Pure Chemical Industries, Ltd, Osaka）.  Sections of the aorta were stained 
with Oil Red O.
MMP-9 and CD68 immunostaining in the aortic arch
　Aortic arch sections（5-μm sections）were dewaxed in xylene and placed on slides in 
the glass slide chamber, which was lled with processing buffer（citric acid buffer, pH 6.0）. 
Sections were blocked for 1 h in phosphate-buffered saline（PBS）containing 5％ normal 
goat serum（NGS）and then exposed to primary antibody overnight at 4℃, either a rabbit 
polyclonal antibody（1 : 200）against rat MMP-9（AB19016, Millipore Co., Billerica, MA）or 
mouse monoclonal antibody（1 : 200）against rat CD68（MAB1435, Millipore）.  The slides 
were then washed in PBS and incubated with anti-rabbit IgG or anti-mouse IgG secondary 
antibody.  After being rinsed in PBS, tissues were incubated with avidin-biotin complex and 
visualized with diaminobenzidine（DAB）.  The sections were finally counterstained with 
hematoxylin and eosin.  Immunostaining of sections was uniformly timed and assessed by 
microscopy 5）.
Table 1.　Nucleotide sequences of the primers used for PCR.
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Statistical analysis
　The statistical signicance of the results was determined using one-way analysis of vari-
ance（ANOVA）followed by a Bonferroni’s test.  Correlations were calculated by Pearson’s 
product moment correlation coefcient.  All data were expressed as mean±S.E.M.  P＜0.05 
was considered signicant.
Results
　Table 2 lists the effects of HFDS on BW, VisF, EpidF, TC, TG and HbA1c in SD-ND, 
SD-HFDS, SHHR-ND and SHHR-HFDS groups.  There was no signicant change in BW 
between the SHHR groups, while BW in the SD groups was increased by HFDS feed-
ing.  In both the SD and SHHR groups, VisF weight and EpidF weight were signicantly 
elevated after ingestion of HFDS.  Compared to the SD-HFDS, there was a significant 
elevation in VisF in the SHHR-HFDS, whereas EpidF levels in the SHHR groups were 
signicantly lower than in the SD groups.  Plasma HbA1c levels were unchanged among 
the SD and SHHR groups.  CT images of abdominal sections, and VisF photo images, after 
abdominal dissection in 11-month-old rats, are shown in Fig. 1.  VisF in these images is in 
accordance with the increase in VisF weight.  On the other hand, the pannicular on CT 
images resembles the increase in EpidF weight.  SHHRs thus tend to an increased VisF 
more readily than SD rats.
　The levels of oxidative stress in rat plasma are shown in Fig. 2A.  The d-ROMs levels 
in SHHR-HFDS（674.1±22.8 U.CARR）were signicantly higher than in SD-ND（297.9±
23.1 U.CARR）, SD-HFDS（425.1±14.3 U.CARR）and SHHR-ND（322.3±12.8 U.CARR）. 
There was a signicantly positive correlation（r＝0.830）between the VisF / BW ratio and 
d-ROMs in all rats（Fig. 2B）.  SHHR-HFDS showed a 3.44-fold increase in MMP-9 mRNA 
expression in WBCs by Q-PCR compared to SD-ND rats（Fig. 3A）.  Moreover, there was 
a signicantly positive relationship（r＝0.465）between d-ROMs and MMP-9 mRNA in all 
rats（Fig. 3B）.  However, the relationship between d-ROMs and MMP-9 mRNA was weak 
Table 2.  Bw, VisF, EpidF, TC, TG, and HbA1c results for 11-month-old SD-ND, SD-
HFDS, SHHR-ND and SHHR-HFDS rats. The results are presented as mean
±S.E.M. 
SD-ND SD-HFDS SHHR-ND SHHR-HFDS
BW（g） 633.4±30.3 699±24.7 600.1±11.5＊ 627.8±16.5
VisF（g） 21.0±2.5 31.9±3.1 18.9±0.7＊ 53.7±3.4##,＊＊, $$
EpidF（g） 14.4±1.6 15.4±1.2 5.6±0.3##, $$ 8.7±0.4#, $$
TC（mg / dL） 61.4±9.3 105.0±17.1 211.0±17.4＊＊, ## 392.6±18.7##,＊＊, $$
TG（mg / dL） 89.7±32.4 128.8±17.6 146.8±40.7 300.0±113.4$$
HbA1c（％） ＜2.5％ ＜2.5％ ＜2.5％ ＜2.5％
＊ : P＜0.05 vs. SD-HFDS. ＊＊ : P＜0.001 vs. SD-HFDS. # : P＜0.005 vs. SD-ND. 
## : P＜0.001 vs. SD-ND. $$ : P＜0.001 vs. SHHR-ND.
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Fig. 2. The graph shows increased d-ROMs test in plasma of SD-ND, SD-HFDS, SHHR-ND and SHHR-
HFDS（A）. Data are provided as mean±S.E.M. ＊ : P＜0.01 vs. SD-ND and SHHR-ND. ＊＊ : P＜
0.001 vs. SD-ND, SD-HFDS and SHHR-ND. A signicant positive correlation（r＝0.83, P＜0.001）
between VisF / BW ratio and d-ROMs was observed in all rats（B）.
A B
Fig. 1. CT images of abdominal sections and VisF images after abdominal dissection in SD-ND（A, E）, 
SD-HFDS（B, F）, SHHR-ND（C, G）and SHHR-HFDS（E, H）at 11 months of age.
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compared to the relationship between the VisF / BW ratio and d-ROMs.  No signicant rela-
tionship was observed between the VisF / BW ratio and MMP-9 mRNA（data not shown）.
　TIMP-1 and MMP-8 mRNA expressions in rat WBCs by Q-PCR are shown in Fig. 4. 
TIMP-1 in SHHR-ND and SHHR-HFDS decreased to 21％ and 46％, respectively, of that 
in SD-ND.  MMP-8 positive WBCs, thought to be polymorphonuclear neutrophil（PMN）- 
type cells, showed no signicant increase in SHHR-HFDS compared to SD-ND.
　Morphological analysis of the aorta from SHHRs and SD rats using Oil Red O showed 
lipid deposition in the subintimal space in both the SHHR-ND and SHHR-HFDS groups
（Fig. 5）, with the deposition more advanced in the SHHR-HFDS group.  Fig. 6 and 7 rep-
resent typical images of aorta immunostained for CD68 and MMP-9, respectively.  Staining 
of CD68, a macrophage marker, is clearly apparent at the aortic intima in SHHR-HFDS, 
while MMP-9 staining was detected mainly at the aortic intima surface.  The staining of 
MMP-9 was almost completely colocalized with CD68 staining and overlapped regions show-
ing lipid deposition.
A B
Fig. 3. The graph shows increased MMP-9 mRNA expression in WBCs of SD-ND, SD-HFDS, SHHR-ND 
and SHHR-HFDS, relative to SD-ND, as determined by Q-PCR（A）. Data are provided as mean
±S.E.M. ＊＊ : P＜0.001 vs. SD-ND, SD-HFDS and SHHR-ND. A signicant positive correlation 
（r＝0.47, P＜0.01）between d-ROMs and MMP-9 mRNA was observed in all rats（B）.
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Discussion
　The present study demonstrated that the increased oxidative stress associated with VisF 
accumulation increased MMP-9 expression in WBCs of SHHR-HFDS.  In addition, the mac-
rophage accumulation and upregulated MMP-9 expression on the aortic intima overlapped 
the regions of lipid deposition in SHHR-HFDS.
　Several previous studies have established a relationship between obesity and lifestyle-relat-
ed diseases.  In particular, VisF obesity is directly correlated with the clustering of lifestyle-
related diseases, leading to various vascular diseases25-27）.  Indeed, our atherogenic factor-
overlapped animal rats accumulate VisF more easily than normal rats, and in the present 
study all rat groups showed increased oxidative stress following VisF accumulation.  There 
was also a signicantly positive relationship between VisF / BW ratio and oxidative stress in 
all groups, with the underlying pathological conditions of hypertension and hyperlipidemia 
having a weak yet direct effect on this relationship.  Systemic oxidative stress, measured by 
urinary 8-epi-PGF2α concentration, was closely associated with visceral fat accumulation in a 
previous study, and the correlation coefcient for VisF and urinary 8-epi-PGF2α concentra-
tion was the highest among all parameters analyzed（r＝0.636, p＜0.0001）28）.  Increased 
oxidative stress is one cause of increased vascular permeability in the visceral fat of obese 
A B
Fig. 4. The graph shows changes in TIMP-1（A）and MMP-8（B）mRNA expression in WBCs of SD-
ND, SD-HFDS, SHHR-ND and SHHR-HFDS, relative to SD-ND, as determined by Q-PCR. Data 
are provided as mean±S.E.M. ＊ : P＜0.05, ＊＊ : P＜0.01 vs. SD-ND, SD-HFDS.
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animals29, 30）.  Another proposed cause relates to the abundant synthesis and secretion of 
angiotensinogen by adipose tissue31, 32）, especially visceral tissue 32, 33）.  Angiotensinogen is 
cleaved by rennin to angiotensin I and then converted to angiotensin II by angiotensin-
converting enzyme in adipose tissue.  Thus, angiotensin II is also produced locally in adipose 
tissue33）.  Angiotensin II induces nicotinamide adenine dinucleotide phosphate（NADPH）
oxidase expression and activation in vascular endothelial cells34, 35）, yielding reactive oxygen 
species（ROS）as a product36, 37）.  Clearly, visceral fat accumulation is closely associated with 
increased oxidative stress.
　MMP-9 and TIMP-1 play important roles in the progression of atherosclerosis38, 39） and 
oxidative stress is associated with MMP-9 expression.  Plasma MMP-9 activity is increased 
in hypertension40） and in high-fat calorie-induced type 2 diabetes mellitus41）.  In the present 
study, SHHR-HFDS exhibited a higher MMP-9 expression in WBCs than other rat groups. 
Furthermore, a positive correlation was found between fractional changes in malondialde-
hyde, a marker of oxidative stress, and MMP-9 in patients with acute coronary syndrome12）. 
Fig. 5. Histological changes in the aorta of 
rats at 11 months of age. The aorta 
tissues（aortic arch）were analyzed by 
Oil Red O staining in SD-ND（A）, 
SD-HFDS（B）, SHHR-ND（C）and 
SHHR-HFDS（D）. Yellow arrows 
indicate lipid depositions（neutral fat）. 
Original magnication, ×200.
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Fig. 6. Immunostaining of CD68 in an aortic 
cross-section（positive staining is brown）. 




Fig. 7. Immunostaining of MMP-
9 in an aortic cross-section
（positive staining is brown）. 
White arrows indicate MMP-
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TIMP-1 is a natural inhibitor of MMP, especially pro-MMP-9, acting to maintain the struc-
tural integrity of basement membranes and protects them from degeneration 14）.  The relative 
balance of MMP-9 and TIMP-1 is thus important in approximating the value of absolute 
MMP-9 activity15）.  TIMP-1 expression is also decreased by hypertension42）, and in the 
present study, TIMP-1 expression in WBCs was decreased in SHHR groups.  Thus, MMP-9 
activity would increase in SHHR-HFDS through down-regulated TIMP-1 expression.  MMP-
8 is released from neutrophils at sites of inammation and vascular lesions, and is associated 
with atherosclerosis 43, 44）.  In this study, MMP-8 expression in WBCs did not increase signi-
cantly ; however, the tendency of MMP-8 expression resembled that of MMP-9 expression. 
Therefore, MMP-8 activity might also increase significantly with the decrease in TIMP-1 
expression 15, 44）.
　There was substantial lipid deposition in the aorta of SHHR-HFDS, whereas few such 
areas were observed in other rats.  Increased VisF, oxidative stress, and MMP-9 expression 
correlated with the observed morphological features of the aortic tissue.  In addition, the 
lipid deposition sites overlapped the staining patterns of both MMP-9 and CD68, with the 
latter marker indicating macrophage accumulation in the aorta45）.
　A typical feature of atherosclerotic lesions is the appearance of lipid-laden foam cells. 
Oxidation of low-density lipoprotein（oxLDL）triggers the generation of a series of oxidation 
byproducts46, 47）.  The avid uptake of oxLDL by macrophage scavenger receptors leads to 
the foam cells as well as fatty streak development in the arterial wall, which is one of the 
earliest stages of atherosclerotic plaque progression47）.  Macrophage MMP’s are signicant 
players in the weakening and rupture of these plaques48）, and MMP-9 mRNA expression 
and activity is high in macrophages49）.  Therefore, MMP-9 is a likely key factor in plaque 
rapture and the subsequent onset of acute coronary syndrome.  Future studies should focus 
on the association with MMP-9 expression and macrophage accumulation.
　In conclusion, the present study suggested that increased oxidative stress generated from 
visceral fat accumulation induces MMP-9 expression and macrophage accumulation on the 
aorta intima of atherogenic factor-overlapped animal model rats.  The SHHR model may 
help in the elucidation and treatment of atherosclerosis.
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